HI-Bio
acquired by Biogen3 known investors
Biotech company developing antibodies to treat autoimmune and inflammatory diseases.
Investors · 3
Frequently asked questions
- What does HI-Bio do?
- Biotech company developing antibodies to treat autoimmune and inflammatory diseases.
- Who are HI-Bio's investors?
- HI-Bio's investors include Arkin Capital, Jeito Capital, Monograph Capital Partners.
- Who acquired HI-Bio?
- HI-Bio was acquired by Biogen.